ReviewNature reviews. Clinical oncology2021

Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm.

Yoshiaki Nakamura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.